Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-29
2010-10-19
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S231200, C540S107000, C544S360000
Reexamination Certificate
active
07816348
ABSTRACT:
Compounds of formula I:wherein X, R2, R3, R5and R6are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
REFERENCES:
patent: 4062682 (1977-12-01), Laridon et al.
patent: 4740519 (1988-04-01), Shroot et al.
patent: 5633388 (1997-05-01), Diana et al.
patent: 6434489 (2002-08-01), Lesburg et al.
patent: 6878727 (2005-04-01), Borchardt et al.
patent: 7112600 (2006-09-01), Hashimoto et al.
patent: 7386398 (2008-06-01), Coulombe et al.
patent: 2003/0236251 (2003-12-01), Beaulieu et al.
patent: 2004/0082635 (2004-04-01), Hashimoto et al.
patent: 2005/0003348 (2005-01-01), Coulombe et al.
patent: 2007/0219176 (2007-09-01), Coulombe et al.
patent: 2008/0045516 (2008-02-01), Beaulieu et al.
patent: 2412718 (2002-01-01), None
patent: 2450033 (2003-06-01), None
patent: 2511301 (2004-08-01), None
patent: 1256628 (2002-11-01), None
patent: 1688420 (2006-08-01), None
patent: 9907733 (1999-02-01), None
patent: 9907734 (1999-02-01), None
patent: 0009543 (2000-02-01), None
patent: 0009558 (2000-02-01), None
patent: 0059929 (2000-10-01), None
patent: 0147883 (2001-07-01), None
patent: 0177113 (2001-10-01), None
patent: 0181325 (2001-11-01), None
patent: 0204425 (2002-01-01), None
patent: 0208187 (2002-01-01), None
patent: 0208198 (2002-01-01), None
patent: 0208244 (2002-01-01), None
patent: 0208256 (2002-01-01), None
patent: 0248172 (2002-06-01), None
patent: 02060926 (2002-08-01), None
patent: 03000254 (2003-01-01), None
patent: 03004458 (2003-01-01), None
patent: 03007945 (2003-01-01), None
patent: 03010140 (2003-02-01), None
patent: 03010141 (2003-02-01), None
patent: 03026587 (2003-04-01), None
patent: 03053349 (2003-07-01), None
patent: 03062228 (2003-07-01), None
patent: 03062265 (2003-07-01), None
patent: 03064416 (2003-08-01), None
patent: 03064455 (2003-08-01), None
patent: 03064456 (2003-08-01), None
patent: 03099274 (2003-12-01), None
patent: 03099316 (2003-12-01), None
patent: 03101993 (2003-12-01), None
patent: 2004030670 (2004-04-01), None
patent: 2004032827 (2004-04-01), None
patent: 2004037855 (2004-05-01), None
patent: 2004039833 (2004-05-01), None
patent: 2004043339 (2004-05-01), None
patent: 2004064925 (2004-08-01), None
patent: 2004065367 (2004-08-01), None
patent: 2004072243 (2004-08-01), None
patent: 2004087714 (2004-10-01), None
patent: 2004093798 (2004-11-01), None
patent: 2004094452 (2004-11-01), None
patent: 2004099241 (2004-11-01), None
patent: 2004101602 (2004-11-01), None
patent: 2004101605 (2004-11-01), None
patent: 2004103996 (2004-12-01), None
patent: 2004113365 (2004-12-01), None
patent: 2005010029 (2005-02-01), None
patent: 2005012288 (2005-02-01), None
patent: 2005014543 (2005-02-01), None
patent: 2005021584 (2005-03-01), None
patent: 2005028501 (2005-03-01), None
patent: 2005030796 (2005-04-01), None
patent: 2005037214 (2005-04-01), None
patent: 2005046712 (2005-05-01), None
patent: 2005049622 (2005-06-01), None
patent: 2005051410 (2005-06-01), None
patent: 2005051980 (2005-06-01), None
patent: 2005054430 (2005-06-01), None
patent: 2005058821 (2005-06-01), None
patent: 2005070955 (2005-08-01), None
patent: 2005080388 (2005-09-01), None
patent: 2005085197 (2005-09-01), None
patent: 2005085242 (2005-09-01), None
patent: 2005085275 (2005-09-01), None
patent: 2005087721 (2005-09-01), None
patent: 2005087725 (2005-09-01), None
patent: 2005087730 (2005-09-01), None
patent: 2005087731 (2005-09-01), None
patent: 2005107745 (2005-11-01), None
patent: 2005113581 (2005-12-01), None
patent: 2005121132 (2005-12-01), None
patent: 2006000085 (2006-01-01), None
patent: 2006007693 (2006-01-01), None
patent: 2006007700 (2006-01-01), None
patent: 2006007708 (2006-01-01), None
patent: 2007087717 (2007-08-01), None
patent: 2008019477 (2008-02-01), None
patent: 2009018656 (2009-02-01), None
patent: 2009018657 (2009-02-01), None
patent: 2009076747 (2009-06-01), None
McKercher et al, Specific inhibitors of HCV polymerase identified using an NS5B with Lower affinity for template/ primer substrare, “Nucleic Acids Research” vol. 32 (2) pp. 422-431, 2004 (abstract and discussion).
Llinas-Brunet et al., Highly Potent and Selective Peptidle-Based Inhibitors of the Hepatitis C virus Serine Protease: Towards Smaller Inhibitors, “Bioorganic & Medicinal Chemistry Letters” vol. 10 (20) pp. 2267-2270, 2000 (abstract and discussion).
Faucher et al, Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans, “Organic Letters” vol. 6 (17) pp. 2901-2904, 2004 (abstract and discussion).
Beaulieu et al., Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency, “Biorganic & Medicinal Chemistry Letters” vol. 14 (4) pp. 967-971 (2004) (abstract and discussion).
Beaulieu et al., Inhibitors of the HCV NS5B polymerase: New hope for the treatment of hepatitis C infections, “Current Opinion in Investigational Drugs” vol. 5 (8) pp. 838-850, 2004 (abstract and discussion).
International Search Report PCT/CA2007/000144.
Abdel-Magid, A.F., et al., “Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures”, J. Org. Chem., 1996, vol. 61, p. 3849.
Ago, H.,et al. “Crystal Structure of the RNA-dependent RNA Polymerase of Hepatitis C Virus”, Structure, vol. 7, No. 11, pp. 1417-1426, USA, Nov. 1999.
Beaulieu, P. L., “Finger loop inhibitors of the HCV NS5B polymerase: Discovery and prospects for new HCV therapy”, Curr. Opin. Drug Discovery & Development, 2006, vol. 9, No. 5, p. 618.
Beaulieu, P. L., “Non-nucleoside inhibitors of the HCV NS5B polymerase: Progress in the discovery and development of novel agents for the treatment of HCV infections”, Curr. Opin. Investigational Drugs, 2007, vol. 8, No. 8, p. 614.
Beaulieu, P. L., “The discover of finger loop inhibitors of the hepatitis C virus NS5B polymerase: Status and prospects for novel HCV therapeutics”, IDRUGS, 2006, vol. 9, No. 1, p. 39.
Berge, S. M., et al., “Pharmaceutical Salts”, Journal of Pharmaceutical Sciences, 1977, vol. 66, No. 1, p. 1.
Bowie, et al., “Deciphering the message in protein sequences: tolerance to amino acide substitutions”. Science, vol. 247, No. 4948, Mar. 1990, pp. 1306-1310.
Bressanelli, S., et al. “Crystal Structure of the RNA-dependent RNA Polymerase of Hepatitis C Virus”, PNAS, vol. 96, No. 23, pp. 13034-13039, USA, Nov. 1999.
Bressanelli, S., et al. “Structural Analysis of the Hepatitis C Virus RNA Polymerase in Complex with Ribonucleotides”, J. Virology. vol. 76, No. 7, pp. 3482-3492, USA, Apr. 2002.
Buck, E., et al., “Preparation of 1-Methoxy-2-(4-Methoxyphenoxy) Benzene”, Org. Syntheses, 2005, vol. 82, p. 69.
Caplus: Hemalatha, R. et al., “QSAR Analysis of 5-substituted-2-Benzoylaminobenzoic acids as PPAR Modulator”, E-Journal of Chemistry, 2004, vol. 1, No. 5, p. 243-250S.
Di Marco, S., et al., “Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric Site”, J. Biological Chemistry, 2005, vol. 280, No. 33, p. 29765.
Giuliano, C. et al., “Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase” Xenobiotica, 2005, vol. 35, No. 10, p. 1035.
Harper, S. et al., “Development and Preliminary Optimization of Indole-N-Acetamide Inhibitors of Hepatitis C Virus NS5B Polymerase”, J. Medicinal Chemistry, 2005, vol. 48, p. 1314.
Harper,S., et al., “Potent Inhibitors of Subgenomic Hepatitis C Virus RNA Replication through Optimization of Indole-N-Acetamide Allosteric inhibitors of the Viral NS5B polymerase”, J. Medicinal Chemistry, 2005, vol. 48, p. 454.
Hennessy, E.J., et al., “A General and Mild Copper-Catalyzed Arylation of Diethyl Malonate”, Organic Letters, 2002, v
Coulombe René
Fazal Gulrez
Rancourt Jean
Stammers Timothy
Thavonekham Bounkham
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Dow David A.
Morris Michael P.
Solola Taofiq A
LandOfFree
Viral polymerase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Viral polymerase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral polymerase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4188437